Austria vs Türkiye: The number of people with susceptibility test result for rifampicin
Austria
86.84
in 2021
Türkiye
87.71
in 2021
Austria rank
80th
Türkiye rank
77th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Türkiye
How they compare
Türkiye currently reports 87.71 against 86.84 in Austria, a difference of 0.87.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 80th and Türkiye ranks 77th of 146 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Türkiye in 1.
Head to head by decade
| Decade | Austria | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.78 | 86.95 | 1.83 | Austria |
| 2020s | 86.89 | 89.12 | 2.23 | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Türkiye?
- Türkiye, at 87.71 against 86.84 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Türkiye?
- 0.87, with Türkiye ahead.
- How many years of comparable data are there for Austria and Türkiye?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Türkiye rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th and Türkiye ranks 77th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.